Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer
about
The role of magnetic resonance imaging in the diagnosis and management of prostate cancerHigh-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancerFocal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyAssessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.Multiparametric MRI in the PSA screening eraThe role of focal therapy in the management of localised prostate cancer: a systematic review.Relative effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of localised prostate cancer: a systematic review and mixed treatment comparison meta-analysis.[Focal prostate cancer therapy: capabilities, limitations and prospects].Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer.Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohortPractice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.Predicting biochemical recurrence in patients with high-risk prostate cancer using the apparent diffusion coefficient of magnetic resonance imaging.Advances in oncologic imaging: update on 5 common cancers.Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer.Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.Robotic Assisted Laparoscopic Prostatectomy after High Intensity Focused Ultrasound Failure.Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.Are we ready for the new wave of focal therapy interventions for men with early prostate cancer?Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal Therapy.The management of rectal bleeding following transrectal prostate biopsy: A review of the current literature.Can we deliver randomized trials of focal therapy in prostate cancer?Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm(2) : correlation with Gleason score and repeatability of region of interest analysis.Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness.[Diagnosis of prostate cancer].Optimizing patient selection for focal therapy-mapping and ablating the index lesion
P2860
Q26849794-2E9FEDA3-1B8A-4766-BA10-3575C62DD60AQ26996937-B24AED9C-96BD-4036-8BF9-F9E76C3D48C3Q30514532-72C36BBA-E288-4E53-A8C6-ACB081C6935DQ33821885-90EBF3FB-2953-4FED-8892-6349AA833ECEQ34177428-A5B00CFF-612C-482E-AFD7-9B7CD01BE9F6Q34266167-F628B3CB-E405-46DB-8C1F-726CE2980301Q34360134-B9B0497E-08E4-4D44-8F4B-092DEBCDBFA7Q34448994-EC46AD1B-577A-43EB-8947-19EF4BADCED0Q35540067-6A7C8656-6B11-4E28-9D28-5809E0B07208Q36306100-9D0F2A5F-4584-41C9-AA1E-D71D2F082D28Q36346204-6C676009-357E-4E85-B6E8-08DCDC54B46FQ36575721-C357F8EB-B41D-48F8-9237-359F1F884311Q36787957-25A58621-1E69-4FE4-809F-A95E0708D343Q36835988-4D19869C-13E2-4E5C-9994-921BCC64C5D2Q37188309-2D462319-7A64-498D-A5B9-B9CEF524D00EQ37589180-15E6B6A7-6611-44D4-8646-39C7E19D8409Q38052458-8825232B-BAC9-4795-86A1-D5F004EEC2B8Q38152243-DFCFF1E9-4D8B-4287-A9E2-DFB6D68B22D7Q38307414-74419069-D012-4D1B-B14A-2D611689BAF3Q38422637-5B4AD57E-921F-40E4-85E6-F7B9FD0D87C4Q38739753-70705304-AD29-4EC6-B8CA-6B85D48752F6Q38871511-B9AD5799-4BE1-4B0D-9D36-A90C9741193FQ39438297-EB5E69E7-F85C-43E7-B044-D84F7C1B1569Q42260486-4F93FA51-F543-4724-8DF1-237C81D595C5Q44487866-CF35D308-720B-42F3-BE9A-6A90D79FFF67Q46939661-E3E4D593-79B8-494A-9892-C834E903E189Q47098355-8BC6CBD6-AEF2-4A2A-AB01-B4039EB2943EQ47240331-F5577B9D-CF6A-4429-929D-9F2D175F2550Q50243071-93E7A4DF-527C-4B0A-9355-90C9DB6D1574Q51022534-FE4D76E0-62FC-43DE-A5DD-A4459390E33EQ53459936-79C2680A-B89B-4D2C-8DCB-EDBD74E96626Q53638885-55DE84C9-8637-4390-9718-F967EE061D77Q58562122-7A64CA36-AED8-467C-A9B9-959A177ED0ED
P2860
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Transatlantic Consensus Group ...... al therapy for prostate cancer
@en
type
label
Transatlantic Consensus Group ...... al therapy for prostate cancer
@en
prefLabel
Transatlantic Consensus Group ...... al therapy for prostate cancer
@en
P2093
P2860
P50
P1433
P1476
Transatlantic Consensus Group ...... al therapy for prostate cancer
@en
P2093
Chris Parker
Hashim U Ahmed
John Kurhanewicz
Larry Goldenberg
Mike W Kattan
Peter Scardino
Sarah Crane
Thomas J Polascik
Transatlantic Consensus Group ...... for Prostate Cancer (appendix)
P2860
P304
P356
10.1111/J.1464-410X.2011.10633.X
P50
P577
2011-11-11T00:00:00Z